GOSS News

Pomerantz LLP Informs Shareholders of Securities Class Action Against Gossamer Bio, Inc. – GOSS

Pomerantz LLP Informs Shareholders of Securities Class Action Filing Against Gossamer Bio, Inc. – GOSS

Pomerantz LLP Informs Shareholders of Class Action Filing Against Gossamer Bio, Inc. – GOSS

Bragar Eagel & Squire, P.C. Reminds Gossamer Investors that a Class Action Lawsuit Has Been Filed Against Gossamer Bio, Inc. (NASDAQ:GOSS) and Encourages Investors with Large Losses to Contact the Firm

DEADLINE ALERT for GOSS, NUAI, and MEDP: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure– Hagens Berman

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GOSS SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026

Pomerantz LLP Informs Shareholders of Securities Class Action Against Gossamer Bio, Inc. – GOSS

GOSS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Gossamer Bio, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!